Tutorial: Advocating for Biomaterials

Timeslot: Friday, April 5, 2019 - 1:45pm to 3:45pm
Track: Thought Leader
Room: Skagit 3

About

Past federal investments in basic biomedical research have led to significant innovations and advancements in medicine. Today however, Congress seems less interested in past accomplishments as they assume new priorities to balance the budget, reduce government, and free private sector to assume long-standing government responsibilities for innovation and discovery. How did Congress make spending decisions to permit federal R&D spending to be flat for over a decade? Learn why Congress is no longer accountable for reduced investments in research. Discover three secrets to making a winning case for federal funding for biomedical research. Learn practical steps to successfully getting your point across to a Member of Congress. Arming yourself with these strategies for the political warfare for biomedical innovation is more than just changing public policy; it is key to changing the future landscape of new biomedical materials, products or procedures.

Abstracts

  • 1:45 PM 405. Invited Speaker - Milan Yager, AIMBE

  • 2:15 PM 406. Invited Speaker,

  • 2:45 PM 407. Invited Speaker,

  • 3:15 PM 408. Invited Speaker

Invited Speaker(s)